The new generic products which were recently developed. Volunteer will receive a single dose of 1 tablet of Rivaroxaban Film-Coated Tablets (20 mg)of either test or reference with 250 mL of drinking w
Sponsors
Bio-innova Co., Ltd.
Conditions
Healthy subjects
Bioequivalence Rivaroxaban Film-Coated Tablets (20 mg)The study is conducted in healthy Thai human volunteers to prevented anticoagulant.
Bioequivalence Rivaroxaban 20 mg tablets
Phase 1
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Rivaroxaban Film-Coated Tablets (20 mg) relative to Originator Rivaroxaban Film-Coated Tablets (20 mg) in healthy Thai volunteers under fed condition
Active, not recruitingTCTR20220629006
Start: 2023-02-07Target: 36Updated: 2026-08-03
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Rivaroxaban 20 mg tablets relative to Xarelto 20 mg tablets, in healthy Thai volunteers under fed condition.
TCTR20240719002
Start: 2025-07-12Target: 28Updated: 2026-08-03